East Coast fever mRNA vaccines – sweetening the promise
The mRNA vaccine platform should help research on East Coast fever subunit vaccines, but it remains unexplored. A theoretical strength of this platform, namely its capacity to prime cytotoxic T lymphocyte responses, is appealing as these, rather than antibodies, are the major mediators of immunity i...
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Elsevier
2025
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/175623 |
Similar Items: East Coast fever mRNA vaccines – sweetening the promise
- An economic assessment of farmer demand in Kenya for a vaccine against East Coast fever
- Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever
- Production and delivery costs of the infection-and-treatment vaccine against East Coast Fever
- Potential demand estimation of east coast fever vaccines in Makuyu division, Kenya: an application of contingent valuation and conjoint analysis.
- Improved vaccines for the control of East Coast Fever: IPSR Innovation Profile
- Farm and livelihood characteristics after ITM vaccination against East Coast fever in Tanzania